These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [MODERN TREATMENT OF HERPETIC KERATITIS]. WILCZEK M; ZYGULSKA-MACHOWA H; WILCZEK Z Pol Tyg Lek; 1964 Jul; 19():1035-7. PubMed ID: 14190843 [No Abstract] [Full Text] [Related]
5. Activity of 1-beta-D-arabinofuranosylcytosine hydrochloride against herpes simplex keratitis. UNDERWOOD GE Proc Soc Exp Biol Med; 1962 Dec; 111():660-4. PubMed ID: 13995366 [No Abstract] [Full Text] [Related]
6. CYTOSINE ARABINOSIDE (CA) AND OTHER NUCLEOSIDES IN HERPES VIRUS INFECTIONS. UNDERWOOD GE; WISNER CA; WEED SD Arch Ophthalmol; 1964 Oct; 72():505-12. PubMed ID: 14191102 [No Abstract] [Full Text] [Related]
7. [On the possibility of recurrence of herpetic keratitis treated with 5-iodo-2'-deoxyuridine (IDU)]. PARDUCCI F; ZUCCHINI G Ann Ottalmol Clin Ocul; 1962 Oct; 88():448-52. PubMed ID: 13941386 [No Abstract] [Full Text] [Related]
8. Antagonism and toxicity of IDU by its degradation products. MALONEY ED; KAUFMAN JE Invest Ophthalmol; 1963 Feb; 2():55-7. PubMed ID: 13932626 [No Abstract] [Full Text] [Related]
9. Comparison of specific antiviral agents in herpes simplex keratitis. KAUFMAN HE; MALONEY ED; NESBURN AB Invest Ophthalmol; 1962 Oct; 1():686-92. PubMed ID: 14031369 [No Abstract] [Full Text] [Related]
10. Use of nucleoside analogues in the treatment of herpes simplex virus eye diseases. Sundmacher R Metab Pediatr Syst Ophthalmol; 1983; 7(2):89-94. PubMed ID: 6686278 [TBL] [Abstract][Full Text] [Related]
11. INHIBITION OF URIDINE RIBONUCLEOTIDE SYNTHESIS BY 5-HALOGENATED-2'-DEOXYURIDINE ANALOGUES. STONE JE Nature; 1964 Oct; 204():190-1. PubMed ID: 14222272 [No Abstract] [Full Text] [Related]